Growth Metrics

Sarepta Therapeutics (SRPT) Total Debt Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 5.94%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 103.99%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.07%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Sarepta Therapeutics 1.86 Bn 1.17 Bn 291.52 Mn -26.37%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -26.37%
Dec 31, 2025 -27.10%
Sep 30, 2025 -12.74%
Jun 30, 2025 -7.08%
Mar 31, 2025 -8.15%
Dec 31, 2024 -8.15%
Sep 30, 2024 -0.74%
Jun 30, 2024 -0.74%
Mar 31, 2024 0.40%
Dec 31, 2023 -19.83%
Sep 30, 2023 -19.84%
Jun 30, 2023 12.23%
Mar 31, 2023 12.33%
Dec 31, 2022 40.79%
Sep 30, 2022 40.90%
Jun 30, 2022 0.72%
Mar 31, 2022 0.71%
Dec 31, 2021 10.52%
Sep 30, 2021 56.31%
Jun 30, 2021 57.46%
Mar 31, 2021 58.60%
Dec 31, 2020 45.55%
Sep 30, 2020 60.50%
Jun 30, 2020 61.04%
Mar 31, 2020 61.59%
Dec 31, 2019 62.14%
Sep 30, 2019 5.05%
Jun 30, 2019 -1.91%
Mar 31, 2019 -1.17%
Dec 31, 2018 -2.44%
Sep 30, 2018 1,228.07%
Jun 30, 2018 3,817.62%
Mar 31, 2018 3,047.13%
Dec 31, 2017 2,569.05%
Sep 30, 2017 68.20%
Jun 30, 2017 -44.52%
Mar 31, 2017 -34.74%
Dec 31, 2016 -22.75%
Sep 30, 2016 -10.72%
Jun 30, 2016 -2.58%
Mar 31, 2016 1,254.23%
Dec 31, 2015 1,228.14%
Sep 30, 2015 783.09%
Jun 30, 2015 1,180.20%
Mar 31, 2015 -5.84%
Dec 31, 2014 -85.13%
Sep 30, 2014 -93.72%
Jun 30, 2014 -5.32%
Mar 31, 2014 -5.19%
Dec 31, 2013 502.28%
Mar 31, 2013 -4.72%
Dec 31, 2012 -4.61%
Dec 31, 2011 -4.21%